Diagnostic utility of exome sequencing in the evaluation of neuromuscular disorders

Abstract

Genome-scale sequencing or analysis of a panel of relevant genes used early in the evaluation of patients with NMDs can provide or clarify a diagnosis and minimize invasive testing in many cases.